Pharmacogenomic Insights: Temozolomide in Glioblastoma

Pharmacogenomics is an emerging field that combines pharmacology and genomics to identify genetic factors influencing individual responses to medications. This innovative approach opens doors to more effective and personalized therapies, promoting patient safety and providing tailored treatment options.

Written by
Anna Tzani
  • Categories
  • Therapeutic Areas
Receive the latest newsletter directly to your inbox

Combining Pharmacology with Genomics

Glioblastoma – An Aggressive Brain Tumor

Temozolomide: Genes of Interest in Glioblastoma

Pharmacogenomic Insights: Temozolomide in Glioblastoma image 0
Figure 1. Dendrogram view of genes and proteins affected by temozolomide in glioblastoma.

Adverse Drug Reactions and Genetic Variations

The Future of Glioblastoma Treatment


More on Therapeutic Areas